Related Experiment Video
Updated: Aug 31, 2025
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
6.9K
Interferon-based treatment of chronic hepatitis D
Lisa Sandmann1,2,3,4, Heiner Wedemeyer1,2,3,5
1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
Summary
Interferon-alfa has been a primary treatment for hepatitis D virus (HDV) infection for decades, benefiting about a third of patients by suppressing viral replication. Further research is needed to identify biomarkers for selecting patients likely to respond to interferon-based therapies.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis D virus (HDV) infection treatment has historically relied on interferon-alfa therapies for over 30 years.
- Pegylated interferons became standard for HDV treatment in the mid-2000s, with ongoing trials exploring personalized treatment strategies.
Purpose of the Study:
- To review the mode of action of interferon alpha against HDV.
- To summarize existing data on interferon treatment efficacy for hepatitis D.
- To provide an outlook on potential combination therapies with novel drugs.
Main Methods:
- Review of clinical trials and case series on interferon-alfa and pegylated interferon treatment for HDV.
- Analysis of data on patient response rates, viral suppression, and clinical outcomes.
- Exploration of current research on novel drug development and combination strategies.
Main Results:
- Interferon treatment leads to persistent HDV replication suppression in approximately 25-33% of patients.
- Few patients achieve functional cure of hepatitis B (HBsAg loss) with interferon therapy.
- Successful interferon treatment is linked to improved long-term clinical outcomes in hepatitis D patients.
Conclusions:
- Pegylated interferon-alfa remains a crucial component in managing hepatitis D, alone or in combination with new agents.
- Development of biomarkers is essential for identifying patients who will benefit most from interferon-based treatments.
- Further research is needed to optimize hepatitis D treatment strategies, including combination therapies.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
257
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
257
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
217
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
217
01:29Viruses with RNA Genomes
96
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
96
01:10Retrovirus Life Cycles
46.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.5K
01:29Immune Response Against Viral Pathogens
890
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
890